Thought Leader Compensation

By Elio Evangelista, Director of Research The United States is still waiting for the Centers for Medicare and Medicaid Services (CMS) to issue its final ruling on how it will implement the disclosure rules outlined in the Physician Payments Sunshine...

By Yanis Saradjian,Director of Consulting Our newly updated Fair-Market Value Benchmarking and Analysis service now provides medical, scientific and regulatory staff at life sciences companies with fair-market value benchmarks for thought leaders and influential...

Six Tips to Help Build the Ideal Thought Leader Database As the industry awaits the release of the delayed Sunshine Act guidelines, pharmaceutical and medical device companies are benefiting from the extra time by reviewing current physician payment reporting...

By Ryan McGuire,Senior Research Analyst A study published in the British Medical Journal has received a lot of attention lately. It highlighted the prevalence of financial conflicts of interest (COI) for researchers sitting on 14 specific guideline-setting...

With a new batch of data (and the launch of our FMV Benchmarking Service), we've spent a lot of time recently combing through our fair-market value (FMV) database. It came as little surprise that, on a global scale, top-tier thought leaders are paid virtually the...

Honoraria and hourly reimbursement are other prominent models As scrutiny over key opinion leader (KOL) payments intensifies in Europe, life sciences companies set fee schedules and establish protocol to ensure fair-market value (FMV). Our recent research show...

As compliance and medical affairs teams prepare for the Sunshine Act, they are relying less on exact compensation limits for key opinion leaders.  “KOL Fair-Market Value and Aggregate Spend: Documentation, Tracking and the Sunshine Act” found that only 35...

Cutting Edge Information offers new assessment and consulting service to help companies set compensation and compliance strategies DURHAM, NC – July 20, 2011 – Pharmaceutical consulting firm Cutting Edge Information has launched a widely expanded benchmarking...

Cutting Edge Information’s new research on European fair-market value benchmarks found that drug manufacturers spend between €153 and €283 for a typical key opinion leader (KOL) engagement. Payments vary by company size; biotechnology companies pay European...

Average physician fee schedules for hourly payments to KOLs have fallen each year since 2006, finds Cutting Edge Information Drug and device manufacturers have responded to criticism over physician payments by decreasing their average level of compensation by...